OBJECTIVES: To demonstrate that novice dosimetry planners efficiently create clinically acceptable IMRT plans for head and neck cancer (HNC) patients using a commercially available multicriteria optimization (MCO) system. METHODS: Twenty HNC patients were enrolled in this in-silico comparative planning …

Background and purpose: Treatment plan verification of intensity modulated radiotherapy (IMRT) is generally performed with the gamma index (GI) evaluation method, which is difficult to extrapolate to clinical implications. Incorporating Dose Volume Histogram (DVH) information can compensate for this. …

To validate the model-based 3D dose calculation performed by the COMPASS system, and to evaluate the use of the combination of model-based and measurement-based 3D dose determination for clinical QA purposes.

To quantify the dosimetric accuracy of the COMPASS correction kernel method, and to determine its ability to detect dose delivery errors caused by MLC leaf mis-positioning.

The COMPASS system (IBADosimetry) is a quality assurance (QA) tool which reconstructs 3D doses inside a phantom or a patient CT. The dose is predicted according to the RT plan with a correction derived from 2D measurements of a matrix detector. This correction method is necessary since a direct reconstruction …

The main objective of this study was to make the transition from a film (2D) based pre-treatment IMRT / IMAT QA into a more efficient and clinical relevant method of verification by reconstructing the dose directly in the patient CT using the COMPASS system. The evaluation of the reconstructed dose includes …

This study explores the capability of the COMPASS system (IBA Dosimetry, Germany) to detect leaf positioning errors of a high resolution MLC with 4mm leaf width using a lower resolution (7.62mm detector spacing) 2D matrix of ionisation chambers